Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II)
Clinical trial NCT07500285 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07500285
- Sponsor
- Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-10
- Primary completion
- 2027-06-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.